Zusammenfassung
Das Delir ist im klinischen Alltag häufig, aber unterdiagnostiziert. Die Behandlung des oft multifaktoriell bedingten schweren Krankheitsbildes, welches mit hoher Mortalität und immensen Kosten für das Gesundheitssystem einhergeht, erfolgt oft spät und beschränkt sich meist auf pharmakologische Maßnahmen. Wir geben einen Überblick zu Kernsymptomen und Risikofaktoren des Delirs, medikamentösen und nichtmedikamentösen Behandlungsstrategien und Möglichkeiten der Delirprävention.
Abstract
Delirium is a severe and common yet under-diagnosed disorder in the clinical routine. Multiple factors may contribute to the development of delirium, which is associated with increased mortality and high healthcare costs. Treatment of delirium is often provided with delay and limited to pharmacological interventions. This article summarizes the key symptoms for delirium as well as risk factors and highlights the pharmacological and non-pharmacological options for treatment and prevention.
Literatur
Dilling DMW, Schmidt MH (2011) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel F0. Klinisch-diagnostische Leitlinien, 8. Aufl. Hogrefe, Bern
Inouye SK, Westendorp RG, Saczynski JS (2014) Delirium in elderly people. Lancet 383(9920):911–922
Hatta K et al (2014) Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry 71(4):397–403
Francis J, Young G (2015) Diagnosis of delirium and confusional states. www.uptodate.com. Zugegriffen: 31.03.2015
Hüfner K, Sperner-Unterweger B (2014) Delir in der Neurologie - Diagnose, Behandlung und Prognose. Nervenarzt 85:427–436
Rundshagen I (2014) Postoperative kognitive Dysfunktion. Dtsch Arztebl Int 111:119–125
Ahmed S, Leurent B, Sampson EL (2014) Risk factors for incident delirium among older people in acute hospital medical units: a systematic review and meta-analysis. Age Ageing 43(3):326–333
van Meenen LC et al (2014) Risk prediction models for postoperative delirium: a systematic review and meta-analysis. J Am Geriatr Soc 62(12):2383–2390
Shi Q et al (2012) Delirium in acute stroke: a systematic review and meta-analysis. Stroke 43(3):645–649
Witlox J, Eurelings L, de Jonghe JEA (2010) Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA 304:443–451
Mach JR Jr. et al (1995) Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study. J Am Geriatr Soc 43(5):491–495
Campbell N et al (2009) The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging 4:225–233
Trzepacz PT (1994) The neuropathogenesis of delirium. A need to focus our research. Psychosomatics 35(4):374–391
Trzepacz P (2000) Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 5:132–148
Cerejeira J, Lagarto L, Mukaetova-Ladinska EB (2014) The immunology of delirium. Neuroimmunomodulation 21(2–3):72–78
Androsova G et al (2015) Biomarkers of postoperative delirium and cognitive dysfunction. Front Aging Neurosci 7:1–16
Downing J, Miyan J (2000) Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol Today 21:281–289
D’Mello C, Le T, Swain M (2009) Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor-alpha signaling during peripheral organ inflammation. Neuroscience 29(7):2089–2102
Steiner LA (2011) Postoperative delirium. Part 1: pathophysiology and risk factors. Eur J Anaesthesiol 28(9):628–636
Cerejeira J et al (2012) The cholinergic system and inflammation: common pathways in delirium pathophysiology. J Am Geriatr Soc 60(4):669–675
Tracey K (2009) Reflex control of immunity. Nat Rev Immunol 9:418–428
Tune L (2002) The role of antipsychotics in treating delirium. Curr Psychiatry Rep 4(3):209–212
Inouye SK et al (1990) Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 113(12):941–948
Trzepacz PT (1999) The delirium rating scale. its use in consultation-liaison research. Psychosomatics 40(3):193–204
National Institut for Health and Care Excellence (NICE) (2010) Delirium: diagnosis, prevention and management. www.nice.org.uk/CG103. Zugegriffen: 09.09.2015
Wong CL et al (2010) Does this patient have delirium? Value of bedside instruments. JAMA 304:779–786
Lai MM, Wong Tin Niam DM (2012) Intracranial cause of delirium: computed tomography yield and predictive factors. Intern Med J 42(4):422–427
Jacobson S, Jerrier H (2000) EEG in delirium. Semin Clin Neuropsychiatry 5(2):86–92
Jenssen S (2005) Electroencephalogram in the dementia workup. Am J Alzheimers Dis Other Demen 20(3):159–166
Rivosecchi RM et al (2015) Nonpharmacological interventions to prevent delirium: an evidence-based systematic review. Crit Care Nurse 35(1):39–50
Caplan GA, Harper EL (2007) Recruitment of volunteers to improve vitality in the elderly: the REVIVE study. Intern Med J 37(2):95–100
Colombo R et al (2012) A reorientation strategy for reducing delirium in the critically ill. Results of an interventional study. Minerva Anestesiol 78(9):1026–1033
Tabet N et al (2005) An educational intervention can prevent delirium on acute medical wards. Age Ageing 34(2):152–156
Lundstrom M et al (2005) A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. J Am Geriatr Soc 53(4):622–628
de Jonghe A et al (2014) Effect of melatonin on incidence of delirium among patients with hip fracture: a multicentre, double-blind randomized controlled trial. CMAJ 186:E547–E556
Al-Aama T et al (2011) Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. Int J Geriatr Psychiatry 26(7):687–694
Chen S et al (2015) Exogenous Melatonin for delirium prevention: a meta-analysis of randomized controlled trials. Mol Neurobiol. doi: 10.1007/s12035-015-9350-8
Kalisvaart KJ et al (2005) Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 53(10):1658–1666
Larsen KA et al (2010) Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics 51(5):409–418
Prakanrattana U, Prapaitrakool S (2007) Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 35(5):714–719
Wang W et al (2012) Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial. Crit Care Med 40(3):731–739
Fok MC et al (2015) Do antipsychotics prevent postoperative delirium? A systematic review and meta-analysis. Int J Geriatr Psychiatry 30(4):333–344
Gilmore ML, Wolfe DJ (2013) Antipsychotic prophylaxis in surgical patients modestly decreases delirium incidence – but not duration – in high-incidence samples: a meta-analysis. Gen Hosp Psychiatry 35(4):370–375
Ford AH, Almeida OP (2015) Pharmacological interventions for preventing delirium in the elderly. Maturitas 81:287–292
Maust DT et al (2015) Antipsychotics, other Psychotropics, and the risk of death in patients with dementia number needed to harm. JAMA Psychiatry 72:438–445
Frölich L, Hausner L (2015) Therapie mit Antipsychotika und Antidepressiva bei Demenzen. Nervenarzt 86:461–467
Lonergan E et al (2007) Antipsychotics for delirium. Cochrane Database Syst Rev 2:CD005594
Han CS, Kim YK (2004) A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45(4):297–301
Hu HDW, Yang H (2004) A prospective random control study comparison of olanzapine and haloperidol in senile delirium. Chongging Med J 8:1234–1237
Skrobik YK1, Bergeron N, Dumont M, Gottfried SB (2004) Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 30(3):444–449
Tahir TA et al (2010) A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res 69(5):485–490
Devlin JW et al (2010) Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 38(2):419–427
Maneeton B et al (2013) Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial. Drug Des Devel Ther 7:657–667
Tanimukai H et al (2014) Novel therapeutic strategies for delirium in patients with cancer: a preliminary study. Am J Hosp Palliat Care. doi:10.1177/1049909II4565019. (Epub ahead of print)
Kirino E (2015) Use of aripiprazole for delirium in the elderly: a short review. Psychogeriatrics 15(1):75–84
Hale GM et al (2015) An evaluation of adverse drug reactions associated with Antipsychotic use for the treatment of delirium in the intensive care unit. J Pharm Pract. doi:10.1177/0897190014566313. (Epub ahead of print)
Lonergan E et al (2009) Benzodiazepines for delirium. Cochrane Database Syst Rev 1:CD006379
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
R. Haussmann gibt an, dass kein Interessenkonflikt besteht. M. Donix: Forschungsförderung durch die Roland Ernst Stiftung und ein Beraterhonorar von Trommsdorff. M. Bauer: Forschungszuwendungen: Deutsche Forschungsgemeinschaft (DFG), Bundesministerium für Bildung und Forschung (BMBF), American Foundation of Suicide Prevention. Beratertätigkeit: AstraZeneca, BristolMyers Squibb, Ferrer Internacional, Merz, Novartis, Janssen, Lilly, Lundbeck, Otsuka, Servier, Takeda. Vortragshonorare: AstraZeneca, Pfizer, Lilly, Lundbeck, Otsuka, Servier.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Haussmann, R., Bauer, M. & Donix, M. Das nichtentzugsbedingte Delir. Nervenarzt 87, 534–542 (2016). https://doi.org/10.1007/s00115-015-0027-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-015-0027-3